These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33234029)

  • 41. In silico, theoretical biointerface analysis and in vitro kinetic analysis of amine compounds interaction with acetylcholinesterase and butyrylcholinesterase.
    Kandasamy S; Loganathan C; Sakayanathan P; Karthikeyan S; Stephen AD; Marimuthu DK; Ravichandran S; Sivalingam V; Thayumanavan P
    Int J Biol Macromol; 2021 Aug; 185():750-760. PubMed ID: 34216669
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis of novel sulfonamides with anti-Alzheimer and antioxidant capacities.
    Gök N; Akıncıoğlu A; Erümit Binici E; Akıncıoğlu H; Kılınç N; Göksu S
    Arch Pharm (Weinheim); 2021 Jul; 354(7):e2000496. PubMed ID: 33749025
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis, Characterization, and Inhibition Study of Novel Substituted Phenylureido Sulfaguanidine Derivatives as α-Glycosidase and Cholinesterase Inhibitors.
    Akocak S; Taslimi P; Lolak N; Işık M; Durgun M; Budak Y; Türkeş C; Gülçin İ; Beydemir Ş
    Chem Biodivers; 2021 Apr; 18(4):e2000958. PubMed ID: 33620128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New 4-phenylpiperazine-carbodithioate-N-phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and α-glucosidase enzymes.
    Mohammadi-Khanaposhtani M; Nori M; Valizadeh Y; Javanshir S; Dastyafteh N; Moaazam A; Hosseini S; Larijani B; Adibi H; Biglar M; Hamedifar H; Mahdavi M; Kamci H; Karakus A; Taslimi P
    Arch Pharm (Weinheim); 2022 May; 355(5):e2100313. PubMed ID: 35132681
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis, structure-activity relationship and molecular docking of 3-oxoaurones and 3-thioaurones as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Mughal EU; Sadiq A; Murtaza S; Rafique H; Zafar MN; Riaz T; Khan BA; Hameed A; Khan KM
    Bioorg Med Chem; 2017 Jan; 25(1):100-106. PubMed ID: 27780618
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and antimicrobial, acetylcholinesterase and butyrylcholinesterase inhibitory activities of novel ester and hydrazide derivatives of 3(2H)-pyridazinone.
    Ozçelik AB; Gökçe M; Orhan I; Kaynak F; Sahin MF
    Arzneimittelforschung; 2010; 60(7):452-8. PubMed ID: 20712136
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Flavonols and 4-thioflavonols as potential acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, structure-activity relationship and molecular docking studies.
    Mughal EU; Sadiq A; Ashraf J; Zafar MN; Sumrra SH; Tariq R; Mumtaz A; Javid A; Khan BA; Ali A; Javed CO
    Bioorg Chem; 2019 Oct; 91():103124. PubMed ID: 31319297
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Some pyrazoles derivatives: Potent carbonic anhydrase, α-glycosidase, and cholinesterase enzymes inhibitors.
    Turkan F; Cetin A; Taslimi P; Gulçin İ
    Arch Pharm (Weinheim); 2018 Oct; 351(10):e1800200. PubMed ID: 30246264
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer's disease: Quinolotacrine hybrids.
    Sadafi Kohnehshahri M; Chehardoli G; Bahiraei M; Akbarzadeh T; Ranjbar A; Rastegari A; Najafi Z
    Mol Divers; 2022 Feb; 26(1):489-503. PubMed ID: 34491490
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Computational studies on the cholinesterase, beta-secretase 1 (BACE1) and monoamine oxidase (MAO) inhibitory activities of endophytes-derived compounds: towards discovery of novel neurotherapeutics.
    Falade AO; Adewole KE; Ishola AA; Gyebi GA; Olajide NR
    J Biomol Struct Dyn; 2023 Apr; 41(6):2540-2554. PubMed ID: 35118932
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel cinnamic acid-tryptamine hybrids as potent butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study.
    Ghafary S; Najafi Z; Mohammadi-Khanaposhtani M; Nadri H; Edraki N; Ayashi N; Larijani B; Amini M; Mahdavi M
    Arch Pharm (Weinheim); 2018 Oct; 351(10):e1800115. PubMed ID: 30284339
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural Isomerism and Enhanced Lipophilicity of Pyrithione Ligands of Organoruthenium(II) Complexes Increase Inhibition on AChE and BuChE.
    Kladnik J; Ristovski S; Kljun J; Defant A; Mancini I; Sepčić K; Turel I
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781544
    [TBL] [Abstract][Full Text] [Related]  

  • 53. BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides.
    Choi RJ; Roy A; Jung HJ; Ali MY; Min BS; Park CH; Yokozawa T; Fan TP; Choi JS; Jung HA
    J Ethnopharmacol; 2016 Aug; 190():219-30. PubMed ID: 27275774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
    Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M
    Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design, synthesis and biological evaluation of benzofuran appended benzothiazepine derivatives as inhibitors of butyrylcholinesterase and antimicrobial agents.
    Mostofi M; Mohammadi Ziarani G; Lashgari N
    Bioorg Med Chem; 2018 Jul; 26(12):3076-3095. PubMed ID: 29866481
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combined QSAR, molecular docking and molecular dynamics study on new Acetylcholinesterase and Butyrylcholinesterase inhibitors.
    Daoud I; Melkemi N; Salah T; Ghalem S
    Comput Biol Chem; 2018 Jun; 74():304-326. PubMed ID: 29747032
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis of some new 3-coumaranone and coumarin derivatives as dual inhibitors of acetyl- and butyrylcholinesterase.
    Alipour M; Khoobi M; Nadri H; Sakhteman A; Moradi A; Ghandi M; Foroumadi A; Shafiee A
    Arch Pharm (Weinheim); 2013 Aug; 346(8):577-87. PubMed ID: 23852709
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ionic liquid-enabled synthesis, cholinesterase inhibitory activity, and molecular docking study of highly functionalized tetrasubstituted pyrrolidines.
    Kumar RS; Almansour AI; Arumugam N; Althomili DMQ; Altaf M; Basiri A; D K; Sai Manohar T; S V
    Bioorg Chem; 2018 Apr; 77():263-268. PubMed ID: 29421701
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and molecular modelling of thiadizole based hydrazone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitory activities.
    Işık A; Acar Çevik U; Karayel A; Celik I; Erçetin T; Koçak A; Özkay Y; Kaplancıklı ZA
    SAR QSAR Environ Res; 2022 Mar; 33(3):193-214. PubMed ID: 35243936
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery of new butyrylcholinesterase inhibitors via structure-based virtual screening.
    Atatreh N; Al Rawashdah S; Al Neyadi SS; Abuhamdah SM; Ghattas MA
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1373-1379. PubMed ID: 31347933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.